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LSH, a protein related to the SNF2 family of chromatin-remodeling ATPases, is required for efficient DNA
methylation in mammals. How LSH functions to support DNA methylation and whether it associates with a
large protein complex containing DNA methyltransferase (DNMT) enzymes is currently unclear. Here we show
that, unlike many other chromatin-remodeling ATPases, native LSH is present mostly as a monomeric protein
in nuclear extracts of mammalian cells and cannot be detected in a large multisubunit complex. However, when
targeted to a promoter of a reporter gene, LSH acts as an efficient transcriptional repressor. Using this as an
assay to identify proteins that are required for LSH-mediated repression we found that LSH cooperates with
the DNMTs DNMT1 and DNMT3B and with the histone deacetylases (HDACs) HDAC1 and HDAC2 to silence
transcription. We show that transcriptional repression by LSH and interactions with HDACs are lost in
DNMT1 and DNMT3B knockout cells but that the enzymatic activities of DNMTs are not required for
LSH-mediated silencing. Our data suggest that LSH serves as a recruiting factor for DNMTs and HDACs to
establish transcriptionally repressive chromatin which is perhaps further stabilized by DNA methylation at
targeted loci.
In vertebrate genomes, DNA methylation patterns are es-
tablished during gametogenesis, embryo development, and cell
differentiation by enzymes of the DNA cytosine methyltrans-
ferase family, which includes the maintenance DNA methyl-
transferase (DNMT) DNMT1 and the de novo methyltrans-
ferases DNMT3A and DNMT3B (1, 24, 45). DNMT1 binds to
PCNA and functions primarily during S phase to restore fully
methylated CpGs on hemimethylated daughter DNA strands
generated during DNA replication (3, 4). DNMT3A and -3B
are able to methylate unmethylated DNA and in mouse em-
bryogenesis are required during gastrulation, when DNA
methylation patterns are established in differentiating cell lin-
eages of the embryo (24). Mice lacking DNMT proteins die
early during embryogenesis and display aberrant expression of
retrotransposons and various imprinted and nonimprinted
genes (14, 18, 24). Genetic studies with plants and mammals
have revealed that additional factors besides DNMTs are re-
quired for the establishment of DNA methylation patterns in
vivo. Loss-of-function mutations in SNF2 family-related puta-
tive chromatin-remodeling ATPases such as the Arabidopsis
thaliana DDM1 (decrease in DNA methylation 1) protein and
its murine homolog Lsh (lymphoid-specific helicase) lead to
dramatic hypomethylation of the genome in Arabidopsis thali-
ana and mice, respectively (5, 16). Unlike animals that are null
for DNMTs, Lsh-deficient mice develop to term but die soon
after birth with symptoms of renal failure (5). Interestingly,
mice expressing a hypomorph allele of Lsh with targeted dis-
ruption of the SNF2 domain survive much longer and display
modest hypomethylation of DNA and premature aging (39).
Collectively, these studies indicate that the low levels of DNA
methylation (30 to 35% of the wild-type level) in Lsh-defi-
cient mice are compatible with embryonic development.
It is largely unknown how DDM1 and Lsh function to assist
DNA methylation. Given the homology of DDM1 and Lsh
with chromatin-remodeling ATPases of the SNF2 family, it has
been suggested that chromatin remodeling by DDM1 and Lsh
may facilitate the processivity of DNMT enzymes on nucleo-
somal DNA templates (20, 28). In agreement with the require-
ment for SNF2-like proteins to support DNA methylation in
vivo, several studies have demonstrated that in vitro DNMT
enzymes methylate DNA assembled into chromatin 10- to 20-
fold less efficiently than naked DNA (11, 25, 31). Whether
DDM1 or Lsh is able to stimulate DNA methylation on nu-
cleosomal templates in vitro has not been demonstrated. How-
ever, it was reported that DDM1 exhibits features common to
the SNF2 family of chromatin-remodeling proteins, such as
ATP hydrolysis upon stimulation by DNA or nucleosomes and
active sliding of mononucleososomes on DNA templates in
vitro (2).
The biochemical properties of mammalian Lsh protein have
not been investigated in detail, nor has it been determined
whether, similar to many other chromatin-remodeling
ATPases, Lsh associates with a large protein complex (22). It is
also unclear whether Lsh directly interacts with DNMTs and
actively recruits them to chromatin. A recent study has found
that Lsh coimmunoprecipitates with de novo DNMTs Dnmt3a
and Dnmt3b and stimulates methylation of nonmethylated ep-
isomal plasmids introduced into mouse embryonic fibroblasts
(45). No interaction between Lsh and maintenance methyl-
transferase Dnmt1 was detected in these assays, suggesting
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that Lsh is involved primarily in de novo DNA methylation of
nonmethylated sequences (45).
To address some of these questions, we focused on the
properties of human Lsh protein, also known as HELLS (for
helicase lymphoid-specific) or PASG (for proliferation-associ-
ated SNF2-like gene). For convenience we refer to this protein
as LSH throughout this paper. Using size exclusion chroma-
tography and sedimentation in sucrose gradients, we demon-
strate that native LSH can be detected mostly as a free mono-
meric protein in nuclear extracts of human cells. Thus, if LSH
associates with other proteins, such complexes are either un-
stable or not very abundant. Nevertheless, when targeted to
GAL4 binding sites upstream of a reporter gene promoter,
LSH acts as an efficient histone deacetylase (HDAC)-depen-
dent transcriptional repressor. The region of LSH required for
transcriptional silencing maps to the N-terminal coiled-coil
motif, suggesting that transcriptional silencing by LSH is inde-
pendent of its putative chromatin-remodeling activity. We fur-
ther demonstrate that LSH coimmunoprecipitates with the
HDACs HDAC1 and HDAC2 and that the DNMTs DNMT1
and DNMT3B interact with LSH in vitro and are essential for
recruitment of HDACs to LSH in vivo. In cells expressing
N-terminally truncated DNMT1 or null for DNMT3B, HDACs
do not efficiently coimmunoprecipitate with LSH, suggesting
that stable association of HDACs with the rest of the LSH
complex requires both DNMTs to be present simultaneously.
Taken together, our data demonstrate that LSH forms a tran-
sient or not very abundant protein complex in vivo and directly
recruits DNMT1, DNMT3B, and HDACs to establish tran-
scriptionally inactive chromatin. Transcriptional silencing by
the LSH complex does not immediately result in methyl-
ation of DNA, but LSH-mediated increase in the local con-
centration of DNMTs on chromatin may eventually lead to
DNA methylation and further stabilize a silenced chromatin
state.
MATERIALS AND METHODS
Size exclusion chromatography and sucrose gradients. A Superose 6 10/
300GL gel filtration column was calibrated with gel filtration standards thyro-
globulin (669 kDa; Stokes radius [Rs]  8.5), apoferritin (443 kDa; Rs  6.1),
alcohol dehyrdogenase (150 kDa; Rs  4.55), bovine serum albumin (66 kDa;
Rs  3.55), and carbonic anhydrase (29 kDa; Rs  2). One milligram of HeLa
nuclear extract or 1 g of purified recombinant LSH was loaded onto a column
preequilibrated with buffer GF150 (20 mM HEPES-KOH [pH 7.9], 3 mM
MgCl2, 10% glycerol, and 150 mM KCl). Fractions (0.5 ml) were collected,
trichloroacetic acid precipitated, and separated on 7% or 10% polyacrylamide
gels. Native and recombinant LSH and native BRG1 were detected by Western
blotting using anti-LSH (sc-46665) and anti-BRG1 (sc-H88) antibodies (Santa
Cruz). The Rs of LSH was derived from the plotted standards. For sucrose
gradients, 50 g of carbonic anhydrase (2.8S), 50 g of bovine serum albumin
(4.3S) 50 g of alcohol dehydrogenase (7.4S), and 30 g of -amylase (9S) were
loaded as standards through a 2-ml linear 5 to 20% sucrose gradient made in
buffer NE2 without glycerol (20 mM HEPES-KOH [pH 7.0], 10 mM KCl, 1 mM
MgCl2, 0.5 mM dithiothreitol, 0.1% Triton X-100, 420 mM NaCl, and protease
inhibitor mix [Sigma P8340]). The protein standard gradient together with an
identical gradient loaded with 500 g HeLa nuclear extract or 1 g recombinant
LSH was spun for 4 h at 50,000 rpm in a Beckman TLS-55 rotor at 4C. Fractions
(100 l) were taken from the top of the gradient and run on 10% polyacrylamide
gels. Protein standards were detected by Coomassie blue staining, and LSH was
detected by Western blotting. The sedimentation coefficient of LSH was derived
from the plotted standards. Calculations to determine the molecular weight of
native LSH were applied as described previously (35) using the equation Mr 
620,  s20,  Rs  N/(1 	 
20,), where Rs is the Stoke’s radius (nm), s20,w is
the sedimentation velocity (S  10	13), 20, is the viscosity of water at 20°C
(0.01002 g  s	1 cm	1), N is Avogadro’s number (6.022  1023  molecules	1),

20, is the density of water at 20°C (0.9981 g  cm3), and  is the partial specific
volume of protein (used 0.725 cm3/g).
Plasmids and reporter assays. Full-length human LSH (kindly provided by
Robert Arceci, The John Hopkins University School of Medicine) or LSH
fragments corresponding to amino acids 1 to 226 and 227 to 838 as well as the
GAL4 DNA binding domain were PCR amplified and cloned into the pcDNA
3.1 vector (Invitrogen). DNMT3B and DNMT1 were cloned into the pEGFP
vector (Clontech). The catalytically inactive DNMT1c/w point mutant was previ-
ously described (34) and was provided by Heinrich Leonhardt. DNMT3Bc/s was
generated by site-directed mutagenic PCR. In reporter assays, GAL4-TK-LUC
(500 ng) and pact-geo (500 ng) plasmids were cotransfected with 500 ng of the
indicated effector plasmids into 2.5  105 HCT116 cells or DNMT knockout
(KO), cells kindly provided by Bert Vogelstein, using JetPEI reagent (Autogen
Bioclear). To test whether LSH-mediated repression was sensitive to HDAC
inhibitors, trichostatin A (TSA) was added to the tissue culture medium after
transfection to a 100 nM final concentration 24 h prior to lysing the cells. For
rescue experiments with HCT116 KO cell lines, 500 ng of DNMT1-green fluo-
rescent protein (GFP) or DNMT3B-GFP plasmid was cotransfected with the
reporter plasmids in the presence or absence of GAL4-LSH or GAL4-LSH(1–
226). All transfection experiments were performed in triplicate. At 48 h post-
transfection, cells were harvested using reporter lysis buffer (Promega), and
detection of luciferase activity was carried out according to the manufacturer’s
guidelines. Luminescence was measured in a TD20/20 luminometer (Turner
Designs). Detection of -galactosidase activity in the same lysates (as described
above) was carried out as described previously (44).
Coimmunoprecipitation experiments. Immunoprecipitations were performed
from HCT116 nuclear extracts (400 g of total nuclear protein) with 4 g
anti-LSH (sc-46665), anti-HDAC1 (sc-7872), anti-HDAC2 (sc-7899), polyclonal
anti-GFP antibody (a kind gift from K. Sawin, Wellcome Trust Centre for Cell
Biology, Edinburgh), anti-Myc (CRUK), or mock control antihemagglutinin
(anti-HA) (CRUK) antibodies. Immunoprecipitated complexes bound to protein
G beads were washed with NE150 buffer (20 mM HEPES-KOH [pH 7.0], 10 mM
KCl, 1 mM MgCl2, 0.5 mM dithiothreitol, 0.1% Triton X-100, 150 mM NaCl,
and protease inhibitors) and run on 7% or 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis. The gels were transferred to nitrocellulose mem-
branes and proteins detected by appropriate primary antibodies (as described
above), secondary horseradish peroxidase-conjugated anti-mouse or anti-rabbit
antibodies (Sigma), and ECL reagent (Amersham). The antibodies used for the
detection of DNMTs were anti-DNMT3B (PA1-884) and anti-DNMT1 (sc-
20701).
In vitro pull-down assays. LSH fragments corresponding to amino acids 1 to
503 and 248 to 883 were cloned into the pGEX 4T1 plasmid in frame with
glutathione S-transferase (GST) tag and designated GST-LSH-N and LSH-C,
respectively. pGEX-HDAC1, -2, and -3 were provided by Ronald Evans (Salk
Institute, La Jolla, CA) and GST-GFP by Ken Sawin. All GST fusion proteins
were expressed in Escherichia coli BL21(DE3) and purified on glutathione-
Sepharose by standard methods. Full-length DNMT3B and a fragment of
DNMT1 corresponding to amino acids 1 to 1125 were cloned into pGAD-T7Rec
(Clontech) in frame with an HA tag. Full-length LSH was cloned into pGBK-T7
(Clontech) in frame with a Myc tag. One microgram of pGADT7-DNMT3B,
pGADT7-DNMT1, or pGBK-LSH was translated in rabbit reticulocyte lysates
(TnT T7 kit; Promega). One hundred nanograms of each GST fusion protein
immobilized on glutathione-Sepharose beads and 5 l of the translation reaction
mixtures were used in pull-down experiments performed in 100 l of NE2 buffer
for 1 h at 4C on a rotating wheel. The beads were washed four times with 700 l
NE2 buffer, and LSH-bound DNMT proteins were detected on Western blots
with appropriate antibodies. To detect interactions of LSH with DNMT1 in the
presence of DNMT3B, 0.5 or 1 g of baculovirus-produced DNMT3B was added
to the pull-down assay mixtures. LSH and DNMT3B were expressed in insect
cells and purified as described previously (2, 38).
Chromatin immunoprecipitations. Chromatin immunoprecipitation assays
were carried out as previously described (13). Briefly, HEK293 cells containing
a stably integrated 5 GAL4-TK-LUC construct (13) were transiently trans-
fected with 10 g of GAL4-LSH 226 or 10 g of pCDNA3.1 GALYBD control
plasmid. At 48 h posttransfection, the cells were cross-linked with formaldehyde,
sheared by sonication, and immunoprecipitated for 2 h at 4°C with the following
antibodies: anti-HA control (CRUK), anti-H3 (Upstate; 05-499, lot 25198),
anti-H3K9ac (Upstate; 07-352, lot 28741), anti-H4 (Upstate; 07-108, lot 25296),
and anti-H4K12ac (Upstate; 07-595, lot 28885). Immunoprecipitated complexes
were then captured on protein G Dynabeads (Invitrogen). Following extensive
washing, DNA was recovered and 1 l of chromatin-immunoprecipitated DNA
was used in 30 cycles of PCR. Primers for the 5 GAL4-TK promoter were
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5AATTGCTCAACAGTATGAACATTTC and 3CAATTGTTTTGTCACGA
TCAAAGGA. Primers for the GAPDH (glyceraldehyde-3-phosphate dehydro-
genase) promoter were 5-GAGGCTGTGAGCTGGCTGTC and 3-CAGAGC
AGAGTAGCAAGAGCAAGG.
RESULTS
Native LSH cannot be detected in a large protein complex.
Within the SNF2 family of ATPases, LSH is most closely
related to the ISWI subfamily of chromatin-remodeling fac-
tors, which have diverse functions in transcriptional regulation
(16, 20). Most SNF2 family members, including ISWI proteins,
have intrinsic ATPase activity but usually associate with more
than one additional polypeptide in vivo (8, 22). These addi-
tional subunits of chromatin-remodeling complexes either
modulate the activity of SNF2 ATPases or target them to
specific chromatin regions (22). Given the possibility that LSH
may act as an accessibility factor for DNMTs and that mouse
Lsh coimmunoprecipitates with Dnmt3a and Dnmt3b, we in-
vestigated whether LSH in human cells can be detected in a
large protein complex. We fractionated HeLa nuclear extract
by size exclusion chromatography and analyzed the elution
profile of LSH by Western blotting. LSH appeared in four of
the eluted fractions (fractions 17 to 20) with a peak corre-
sponding to a molecular mass of about 150 kDa (Fig. 1A, top).
In comparison, another chromatin-remodeling protein, BRG1,
which is usually present within a 2-MDa complex (26, 36),
eluted at a much higher molecular mass as expected (fractions
5 to 11) (Fig. 1A, middle). Since LSH eluted at an apparent
molecular mass slightly greater than its theoretical mass of97
kDa, we considered the possibility that it may associate with a
relatively small protein(s). However, in a similar experiment
recombinant LSH purified from insect cells eluted with a pro-
file very similar to that of the native LSH, suggesting that the
vast majority of LSH in HeLa nuclear extracts does not asso-
ciate with additional proteins (Fig. 1A, bottom). Nuclear ex-
tracts from other human cell lines, cells synchronized in dif-
ferent stages of the cell cycle (see Fig. S1 in the supplemental
material), and mouse embryonic stem (ES) cells, as well as
extracts prepared from nuclear pellets, containing most of the
insoluble chromatin, showed identical elution of LSH at 150
kDa (not shown).
The molecular mass of a native protein or a protein complex
can be determined accurately by an equation derived by Siegel
and Monty, which combines the Stokes radius (a hydrodynamic
radius of a molecule freely tumbling in solution) calculated
from size exclusion chromatography with the sedimentation
coefficient determined by separation in sucrose gradient (35).
Based on the elution profile of protein standards from size
exclusion chromatography we calculated the Stokes radius of
LSH to be 4.94 nm. To establish the sedimentation coefficient
of LSH, we fractionated HeLa and mouse ES cell nuclear
extracts on 5 to 20% sucrose gradients and detected LSH in the
gradient fractions by Western blots (Fig. 1B). In these exper-
iments the sedimentation coefficient of both human and mouse
LSH was calculated to be 4.5S, relative to protein standards.
Applying the calculated Stokes radius and sedimentation co-
efficient of LSH in the Siegel-Monty equation, we derived a
molecular mass of 91.5 kDa. The calculated molecular mass of
native LSH is close to the predicted theoretical mass of LSH
monomer (97 kDa), confirming that the vast majority of LSH
FIG. 1. Native LSH is a monomer in nuclear extracts of human cells. (A) HeLa nuclear extracts and recombinant LSH purified from insect cells
were fractionated on a Superose 6 size exclusion column and run on sodium dodecyl sulfate-polyacrylamide gels. LSH and BRG1 proteins were
detected in the collected fractions by Western blotting with appropriate antibodies. The molecular masses and Stokes radii (Rs) of marker proteins
used to calibrate the column are indicated at the top. (B) HeLa nuclear extracts and recombinant LSH were fractionated in 5 to 20% sucrose
gradients. LSH was detected in gradient fractions on Western blots with anti-LSH antibodies. Sedimentation coefficients of marker proteins are
indicated above the blot.
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protein in nuclear extracts of mouse and human cells is present
as a free monomeric peptide.
LSH is an HDAC-dependent transcriptional repressor.
Given that in fractionation experiments we failed to detect
LSH within a large protein complex, we decided to explore
whether LSH could interact transiently with other proteins.
We initially intended to use a full-length GAL4 binding do-
main (GAL4BD)-tagged LSH in a yeast two-hybrid screen.
However, we found that GAL4BD-LSH strongly repressed
adenine and histidine genes in yeast reporter strains. The Sac-
charomyces cerevisiae genome encodes a protein, YFR038W,
which shares 39% identity and 57% similarity with human
LSH. Therefore, it was possible that the mammalian protein
could mimic some of the protein-protein interactions of
YFR038W that facilitate transcriptional repression. To inves-
tigate further whether LSH could act as a transcriptional re-
pressor in mammalian cells, we cotransfected colorectal
HCT116 cells with a plasmid expressing full-length LSH fused
to GAL4BD and two reporter plasmids. The first reporter
plasmid carried five GAL4 binding sites upstream of a thymi-
dine kinase (TK) promoter driving the expression of the firefly
luciferase gene, while the other control plasmid lacked GAL4
binding sites and expressed -galactosidase from an actin pro-
moter. The effect of LSH on transcription from the targeted
and nontargeted reporter was measured as a ratio of luciferase
to -galactosidase expression. A GAL4BD-tagged transcrip-
tional repression domain (TRD) of methyl-CpG binding pro-
tein MeCP2, which is known to strongly repress transcription
in such assays, served as a control (21). In these experiments
the full-length GAL4BD-LSH as well as GAL4BD-MeCP2
consistently reduced the expression of the luciferase reporter
to about 20 to 25% and 10%, respectively, of the levels ob-
served in cells transfected with an empty vector (Fig. 2B). This
suggests that, like MeCP2, LSH can function as an efficient
transcriptional repressor when targeted to a promoter of a
reporter gene in human cells.
FIG. 2. LSH functions as an HDAC-dependent transcriptional repressor in vivo. (A) Schematic drawing of the full-length LSH and truncated
LSH proteins fused to a GAL4BD. The functional domains of LSH, such as the coiled-coil domain (CC), the nuclear localization signal (NLS),
and the eight conserved SNF2 motifs in the SNF2N and helicase domains, are indicated. (B) GAL4BD fusions of LSH were cotransfected into
HCT116 cells with a luciferase reporter plasmid carrying GAL4 binding sites upstream of TK promoter and a control plasmid expressing
-galactosidase from an actin promoter. The relative expression of the reporters represents the ratio of luciferase to -galactosidase products.
MeCP2 was used as a control. The white bars represent experiments carried out in the presence of 100 nM TSA, which partially alleviates LSH-
and MeCP2-mediated repression of the luciferase reporter. The error bars represent standard deviations of the means. (C) Coimmunoprecipitation
experiments with anti-LSH, anti-HDAC1, and anti-HDAC2 antibodies from HCT116 nuclear extracts. Anti-HA antibodies were used in mock
immunoprecipitations (IP) to control for nonspecific protein binding. (D) Chromatin immunoprecipitation with antibodies against acetylated
H3-K9 and H4-K12. The TK promoter in cells transfected with GAL4BD-LSH is hypoacetylated compared to the GAPDH promoter used as an
internal control. Anti-HA is a nonspecific control antibody.
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To investigate whether a specific domain of LSH was re-
sponsible for transcriptional silencing, we tested several LSH
deletion constructs in the luciferase reporter assay. Interest-
ingly, the N-terminal portion of LSH (amino acids 1 to 226),
containing a predicted coiled-coil motif, was sufficient to re-
press the reporter gene to levels comparable to those observed
with full-length LSH. A polypeptide corresponding to the
SNF2 and helicase domains of LSH (amino acids 226 to 238),
did not significantly affect the expression of the luciferase re-
porter (Fig. 2A and B). These experiments indicate that the
226-amino-acid coiled-coil region in the N terminus of LSH
functions as a TRD and is sufficient for silencing of the lucif-
erase reporter.
Since coiled-coil regions of many proteins are engaged in
protein-protein interactions, we asked whether the TRD of
LSH functionally cooperates with corepressor proteins such as
HDACs. Consistent with this hypothesis, transcriptional re-
pression by MeCP2, full-length LSH, and LSH(1–226) was
partially alleviated when we repeated the luciferase reporter
assays in the presence of the deacetylase inhibitor TSA (Fig.
2B). This indicates that transcriptional repression by LSH may
operate through an interaction between the coiled-coil domain
and HDACs. To explore this further, we asked whether
HDACs coimmunoprecipitate with the endogenous LSH from
HCT116 nuclear extracts. Antibodies against LSH but not con-
trol anti-GFP antibodies (mock immunoprecipitation) immu-
noprecipitated LSH and coimmunoprecipitated HDAC1 and
HDAC2 (Fig. 2C). We could also detect LSH in reciprocal
immunoprecipitations with anti-HDAC1 and anti-HDAC2 an-
tibodies (Fig. 2C). Additionally, chromatin immunoprecipita-
tions from cells carrying stably integrated copies of the lucif-
erase reporter showed a threefold decrease of acetylated lysine
9 of histone H3 and a twofold decrease of acetylated lysine 12
of H4 at the TK promoter after the cells were transfected with
GAL4BD-LSH (Fig. 2D). Further RNA interference knock-
down experiments with HDAC1 and HDAC2 in HCT116 cells
revealed that depletion of these two HDACs, but not HDAC3,
could, similarly to TSA treatment, alleviate the repression of
luciferase reporter (see Fig. S2 in the supplemental material).
This indicates that HDAC1 and HDAC2 are essential for
LSH-mediated repression.
Transcriptional repression by LSH requires DNMT1 and
DNMT3B. Zhu et al. have recently reported that mouse Lsh
coimmunoprecipitates with the de novo DNMTs Dnmt3a and
Dnmt3b, but not with the maintenance DNMT Dnmt1, from
extracts of mouse embryonic fibroblasts (45). Dnmt1, Dnmt3b,
and Dnmt3a have also been shown to interact with each other
and to coimmunoprecipitate and copurify with HDAC1 and
HDAC2 (Fig. 3A) (9, 17, 31–33). Given all these complex
interactions, we next investigated whether DNMTs contribute
to LSH-mediated transcriptional repression. KO HCT116 cell
lines that are genetically null for DNMT1, DNMT3B, DNMT1
and DNMT3B, or DNMT3A and DNMT3B have been gener-
ated by homologous recombination (15, 29, 30). Subsequently
it was found that most DNMT1 KO cell lines, including the
DNMT1/DNMT3B double-KO (DKO) line, express a trun-
cated DNMT1 protein missing 150 amino acids of the N
terminus, including the regions essential for binding to
DNMT3A, DNMT3B, and PCNA (Fig. 3A; see Fig. 6A) (6,
37). To our surprise, neither GAL4BD-LSH nor GAL4BD-
LSH(1–226) repressed the reporter luciferase gene in DNMT1
KO and DNMT3B KO HCT116 cells (Fig. 3B and C). The
same was observed in DNMT1/DNMT3B DKO and DNMT3A/
DNMT3B DKO cells (not shown). However, when we cotrans-
fected Dnmt1-GFP with either GAL4BD-LSH or GAL4BD-
LSH(1–226) and the reporter plasmids into DNMT1 KO cells,
luciferase expression was reduced to levels comparable to
those observed in wild-type HCT116 cells (Fig. 3B). Interest-
ingly, a catalytically inactive Dnmt1 carrying a single point
mutation, C1229W (34), also rescued LSH-mediated repres-
sion in DNMT1 KO cells as well as wild-type Dnmt1. This
indicates that the enzymatic activity of DNMT1 is not required
for transcriptional silencing of the luciferase reporter.
To determine which region of DNMT1 is required for LSH-
mediated repression, we tested whether shorter DNMT1 con-
structs could restore the repression of the luciferase reporter in
DNMT1 KO cells (Fig. 3A). DNMT1(1–1125)-GFP, which
contains the known interaction sites with DNMT3A,
DNMT3B, and HDACs but is lacking the C-terminal catalytic
domain, could partially restore the repression by GAL4BD-
LSH and GAL4BD-LSH(1–226), while the shorter proteins
DNMT1(1–701)-GFP and DNMT1(1–250)-GFP did not (Fig.
3B). This suggests that a relatively large portion of the
DNMT1 N terminus and perhaps some of the C-terminal
amino acids are involved in protein-protein interactions that
are crucial for LSH-mediated repression. Cotransfection of
DNMT3B-GFP with GAL4BD-LSH or GAL4BD-LSH(1–
226) into DNMT1 KO cells also led to a modest (30%)
decrease of transcription from the reporter gene (Fig. 3B).
This indicates that elevated levels of DNMT3B are not suffi-
cient to restore LSH-mediated repression in cells expressing
low levels of truncated DNMT1.
We next attempted to rescue the LSH-mediated repression
of the luciferase reporter in DNMT3B KO cells. As in the case
of DNMT1, when we cotransfected either GAL4BD-LSH or
GAL4BD-LSH(1–226) and the reporter plasmids with either
wild-type GFP-DNMT3B or catalytically inactive GFP-
DNMT3BC640S, the repression of the luciferase gene was
largely restored (Fig. 3C). Interestingly, cotransfection of
GAL4BD-LSH with DNMT1-GFP into DNMT3B KO cells
could also reduce the expression of the luciferase reporter by
approximately 45 to 50%, indicating that DNMT1, when over-
expressed, could (although not very efficiently) compensate for
the lack of DNMT3B (Fig. 3C). Collectively, these experiments
demonstrate that both DNMT1 and DNMT3B are required
for effective GAL4-LSH-mediated transcriptional silencing.
The interaction of LSH with HDAC1 and HDAC2 is lost in
DNMT KO cells. Given that the repression by LSH was sen-
sitive to TSA and that HDAC1 and HDAC2 coimmunopre-
cipitated with LSH from nuclear extracts of wild-type HCT116
cells, we next examined whether these interactions remain
intact in DNMT KO cells, where GAL4BD-LSH was unable to
silence the reporter gene. When we immunoprecipitated the
endogenous LSH from either DNMT1 KO or DNMT3B KO
extracts, we could not detect HDAC1 and HDAC2 in anti-LSH
immunoprecipitations (Fig. 4A, B, C, and D, top panels; com-
pare with Fig. 2C). Consistently, anti-HDAC1 and anti-
HDAC2 antibodies efficiently immunoprecipitated HDACs
but failed to coimmunoprecipitate LSH from extracts of
DNMT1 and DNMT3B KO cells (Fig. 4A, B, C, and D, bottom
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FIG. 3. Transcriptional repression by LSH requires DNMT3B and the N-terminal portion of DNMT1. (A) Schematic representation of
DNMT1 and DNMT3B proteins with their functional domains. The cysteine-rich putative DNA binding CxxC domain, bromo-adjacent homeobox
motifs (BAH), GK-rich repeats, the domain involved in targeting to replication foci, and the catalytic part of DNMT1 are indicated. Mapped
interactions with DNMT3A, DNMT3B, PCNA, and HDAC1 and -2 are shown above the diagram. The dashed line indicates the portion of
DNMT1 that has been spliced out in DNMT1 KO HCT116 cells with targeted disruption of the DNMT1 gene (6, 37). The DNMT3B protein
contains a DNA binding PWWP motif, a PHD, domain and a conserved catalytic DNMT domain. The portions of DNMT3B interacting with
DNMT1 and DNMT3A are indicated. (B) Neither full-length GAL4BD-LSH nor the TRD of LSH, GAL4-LSH(1–226), could silence the
luciferase reporter in DNMT1 KO cells. Cotransfection of GAL4BD-LSH proteins together with wild-type GFP-tagged DNMT1, catalytically
inactive DNMT1C/W, and the N-terminal portion of DNMT1(1–1125) can rescue the repression of luciferase reporter in DNMT1 KO cells. Shorter
N-terminal DNMT1 proteins [DNMT1(1–250) and DNMT1(1–701)] did not rescue the repression of the luciferase reporter gene. DNMT3B was
used as an additional control. Error bars indicate standard deviations. (C) GAL4BD-LSH and GAL4BD-LSH(1–226) did not repress the luciferase
reporter in DNMT3B KO cells. Cotransfection of LSH proteins with either GFP-DNMT3B or a catalytically inactive GFP-DNMT3BC/S restored
the repression of the reporter to levels observed in wild-type HCT116 cells. Cotransfection of GAL4BD-LSH with GFP-DNMT1 also reduced the
repression of luciferase in DNMT3B KO cells, although not as efficiently as DNMT3B.
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panels). As the protein levels of LSH, HDAC1, and HDAC2 in
KO cells did not differ significantly from those in the wild-type
HCT116 cells, these experiments indicate that DNMT1 and/or
DNMT3B could either directly or indirectly recruit HDAC1
and HDAC2 to LSH. Notably, the presence of both DNMTs is
required to promote stable interactions of HDACs with LSH.
LSH coimmunoprecipitates with DNMT1 and DNMT3B.
Our experiments thus far suggested that LSH participates in a
protein complex (or complexes) that contains DNMT1,
DNMT3B, HDAC1, and/or HDAC2. To investigate further
whether we could detect an interaction between LSH and
DNMT1, we cotransfected DNMT1 KO cells with GAL4DB-
LSH and DNMT1-GFP and used anti-GAL4 and anti-GFP
antibodies for immunoprecipitation experiments. Anti-GFP
antibodies detected DNMT1-GFP in anti-GAL4 immunopre-
cipitations but not in control anti-HA immunoprecipitations,
suggesting that GAL4BD-LSH and DNMT1-GFP interact
with each other (Fig. 5A, top panel). In similar experiments we
found that GAL4DB-LSH and DNMT3B-GFP cotransfected
into DNMT3B KO cells also coimmunoprecipitate (Fig. 5A,
FIG. 4. The interactions of LSH with HDACs are lost in DNMT KO cells. (A and B) Endogenous LSH, HDAC1, and HDAC2 could be
efficiently immunoprecipitated (IP) from extracts of DNMT1 KO cells. However, LSH could not be detected in HDAC immunoprecipitations, nor
was HDAC1 or HDAC2 detected in LSH immunoprecipitations. IgG, immunoglobulin G. (C and D) LSH, HDAC1 and HDAC2 do not
coimmunoprecipitate from extracts of DNMT3B KO cells. Anti-GFP antibodies were used as a control for nonspecific interactions.
FIG. 5. The coiled-coil TRD domain of LSH interacts with DNMTs. (A) GAL4BD-LSH coimmunoprecipitated with GFP-DNMT1 when both
proteins were coexpressed in DNMT1 KO cells. We could detect only about 20% of GFP-DNMT1 in the immunoprecipitations (IP) with
anti-GAL4BD antibodies. GAL4BD-LSH coimmunoprecipitated more efficiently with GFP-DNMT3B when both proteins were coexpressed in
DNMT3B KO cells. WB, Western blot. (B) GAL4BD-LSH(1–333) protein, containing the coiled-coil TRD domain of LSH, coimmunoprecipitates
with GFP-DNMT1 and GFP-DNMT3B from extracts of DNMT1 and DNMT3B KO cells, respectively. Anti-HA antibodies (mock immunopre-
cipitation) were used as a control.
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bottom panel). Consistent with our reporter assays, when we
cotransfected the cells with the coiled-coil TRD domain of
LSH and either DNMT1-GFP or DNMT3B-GFP, we could
detect LSH(1–333) coimmunoprecipitating with each of the
two DNMTs (Fig. 5B). These experiments clearly demonstrate
that the TRD of LSH is necessary and sufficient for the inter-
action of LSH with DNMT1 and DNMT3B in vivo.
DNMT3B is required for the recruitment of DNMT1 to
LSH. As the luciferase reporter assays and coimmunoprecipi-
tation experiments described above relied on overexpression of
tagged proteins, we next examined whether the endogenous
LSH interacts with DNMTs in HCT116, DNMT1, and
DNMT3B KO cells. In agreement with other studies (6, 37), an
antibody against the C terminus of DNMT1 detected a trun-
cated DNMT1 protein in nuclear extracts of DNMT1 KO and
DNMT1/DNMT3B DKO1 cells compared to the wild-type
HCT116 and DNMT1/DNMT3B DKO8 cells (Fig. 6A, top
panel). As observed by others, the truncated DNMT1 protein
was significantly more abundant in one of the DKO cell lines
(DKO1) than in the KO cell line, where DNMT1 was barely
detectable (Fig. 6A, top panel). We did not detect DNMT3B
protein either in DNMT3B KO or in any of the two DKO cell
lines (Fig. 6A, bottom panel). We further used extracts from
four of these cell lines, HCT116, DNMT1 KO, DNMT3B KO,
and DKO1, to immunoprecipitate LSH and asked whether
DNMT1 and DNMT3B could be detected in LSH immuno-
precipitations (Fig. 6B, top panel). DNMT3B was present in
anti-LSH immunoprecipitations from HCT116 cells, as ex-
pected, but it was also detectable in anti-LSH immunoprecipi-
tations from DNMT1 KO cells (Fig. 6B, middle panel). How-
ever, DNMT1 coimmunoprecipitated with LSH only from
extracts of wild-type HCT116 cells and not from extracts of
DNMT3B KO or DKO1 cells (Fig. 6B, bottom panel). These
results indicate that DNMT1 does not efficiently interact with
LSH in the absence of DNMT3B (Fig. 6A). On the other hand,
the presence of DNMT1 may not be required for the interac-
tion of DNMT3B with LSH, given that approximately equal
amounts of DNMT3B coimmunoprecipitate with LSH from
HCT116 and DNMT1 KO cells expressing a truncated
DNMT1 that does not contain the DNMT3B interaction do-
main (Fig. 3A and 6A). Taken together with the reporter
luciferase assays, these immunoprecipitation experiments sug-
gest that LSH may exist in a complex with DNMT3B with or
without DNMT1. However, an LSH complex containing
DNMT1, HDAC1, and HDAC2 must also include DNMT3B.
DNMT3B directly binds to LSH, while DNMT1 and HDACs
do not. To explore whether any of the proteins that coimmu-
noprecipitate with LSH bind to LSH directly, we expressed and
purified from E. coli two GST-tagged recombinant LSH
polypeptides, designated LSH-N and LSH-C (Fig. 7A). LSH-N
contains amino acids 1 to 503 of LSH and includes the N-
terminal coiled-coil and the SNF2 domain. LSH-C corre-
sponds to amino acids 248 to 883 and includes the SNF2
domain and the remainder of the LSH C terminus. We used
these two proteins bound to glutathione-Sepharose beads or a
control GST-GFP protein to pull down HA-tagged DNMT1
(amino acids 1 to 1125) and full-length DNMT3B in vitro
translated in rabbit reticulocyte lysate. Neither LSH-N nor
LSH-C could bind DNMT1 in these assays (Fig. 7B). In con-
trast, LSH-N but not LSH-C or GFP efficiently pulled down
DNMT3B (Fig. 7B). As DNMT1 and DNMT3B are known to
bind each other (17) and LSH did not coimmunoprecipitate
with DNMT1 from extracts of DNMT3B-deficient cells, we
asked whether LSH-N would be able to pull down DNMT1
when DNMT3B was present. To investigate this, we added
increasing amounts of recombinant DNMT3B expressed and
purified from insect cells to reticulocyte lysate containing in
vitro-translated DNMT1 (Fig. 7C, bottom panel). We could
detect increasing amounts of DNMT1 being pulled down by
GST-LSH-N only when the baculovirus-produced DNMT3B
FIG. 6. The interaction of LSH with DNMT1 in vivo requires DNMT3B. (A) Western blots (WB) with antibodies against the C terminus of
DNMT1 and the N terminus of DBMT3B on nuclear extracts of HCT116 and KO cell lines. Note that a truncated form of DNMT1 is detectable
in DNMT1 KO (D1 KO2) cells as well as in DNMT1/DNMT3B DKO (DKO1) cells, while a second DKO cell line (DKO8) expresses full-length
DNMT1. DNMT3B is detectable only in HCT116 and DNMT1 KO2 cells. In the top panel, the full-length and the truncated DNMT1s are
indicated with arrowheads. The asterisks indicate nonspecific bands that serve as loading controls. (B) Anti-LSH antibodies efficiently immuno-
precipitate LSH from nuclear extracts of HCT116 and KO cells. In identical anti-LSH immunoprecipitations (IP), DNMT3B immunoprecipitates
with LSH from HCT116 and DNMT1 KO extracts, indicating that the N terminus of DNMT1 is not required for the interaction of DNMT3B with
LSH. In contrast, DNMT1 coimmunoprecipitates with LSH only from HCT116 cells, suggesting that the presence of DNMT3B mediates the
recruitment of DNMT1 to LSH.
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was present (Fig. 7C). Consistent with our coimmunoprecipi-
tation assays, these experiments imply that DNMT3B directly
binds to the N terminus of LSH, while the interaction of
DNMT1 with LSH in vitro and in vivo requires the presence of
DNMT3B.
In order to examine whether HDAC1 and HDAC2 could
directly bind to LSH, DNMT1, or DNMT3B, we expressed
GST-tagged full-length HDAC1, HDAC2, and, as a control,
HDAC3 in E. coli and bound them to glutathione-Sepharose
(Fig. 7D). We next used the Sepharose-bound HDAC proteins
to pull down in vitro-translated HA-tagged DNMT1(1–1125),
full-length DNMT3B, and Myc-tagged LSH (Fig. 7E). In
agreement with previous reports, we could detect DNMT1
bound to HDAC1 and HDAC2 but not to HDAC3 (Fig. 7E,
top panel). However, neither DNMT3B nor LSH was pulled
down by GST-HDAC1, -2, or -3 (Fig. 7E, middle and bottom
panels). These in vitro experiments are consistent with our
reporter assays and coimmunoprecipitation results suggesting
that DNMT1 recruits HDAC1 and HDAC2 to the LSH-bound
DNMT3B (Fig. 8).
DISCUSSION
The plant SNF2 family protein DDM1 and its mammalian
homolog LSH were initially identified as proteins essential for
the establishment of DNA methylation in vivo (5, 16). DDM1-
deficient plants and mice with targeted disruption of the Lsh
gene develop with dramatically reduced levels of methylated
cytosine within their genomes and are defective in silencing of
various transposable elements and a few specific genes (7, 12,
19). In mice, lack of Lsh is not essential for embryonic devel-
opment but leads to postnatal death (5). Cytological studies
FIG. 7. LSH directly interacts with DNMT3B but not with DNMT1 or HDACs. (A) A Coomassie blue-stained gel shows GST-tagged purified
GFP, LSH-N, and LSH-C proteins used in the pull-down assays (B and C). (B) The N terminus of LSH binds in vitro-translated DNMT3B. Neither
the N terminus nor the C terminus of LSH pulls down in vitro-translated DNMT1 (amino acids 1 to 1125). WB, Western blot. (C) GST-LSH-N
can pull down DNMT1 in the presence of recombinant DNMT3B (0.5 and 1 g). (D) A Coomassie blue-stained gel shows purified GST-HDAC1,
HDAC2, and HCAC3. (E) GST-HDAC1 and GST-HDAC2 pull down in vitro-translated DNMT1 but not DNMT3B or LSH.
FIG. 8. A model of how the LSH-associated protein complex acts
to repress transcription. Our experiments are consistent with a model
where DNA-bound LSH recruits a complex that includes DNMT3B,
DNMT1, HDAC1, and HDAC2. LSH-associated HDACs remove
acetyl groups (Ac) from histone tails, generating deacetylated chro-
matin incompatible with transcriptional activation. LSH does not di-
rectly interact with DNMT1 and HDACs but requires DNMT3B for
the assembly of the repressive complex. On the other hand, HDAC1
and HDAC2 require both DNMT1 and DNMT3B for association with
the LSH complex. The order of these interactions explains why in cells
expressing N-terminally truncated DNMT1, which does not bind
DNMT3B, or in cells lacking DNMT3B, LSH-mediated repression is
disrupted.
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and experiments with ES cells have shown that although Lsh is
present together with DNMT1 at replication foci during late S
phase, Lsh is dispensable for maintenance of DNA methyl-
ation on replicating episomal plasmids (42, 45). It was further
found that Lsh coimmunoprecipitates with de novo methyl-
transferases Dnmt3a and Dnmt3b and that cells treated with
Lsh small interfering RNA have reduced de novo DNA meth-
ylation (45). Taken together, these studies led to the conclu-
sion that Lsh is involved primarily in de novo DNA methyl-
ation but is dispensable for the maintenance of DNA
methylation during DNA replication.
Despite the important role of Lsh in supporting efficient
DNA methylation in mammalian cells, very little is known
about how this protein interacts with the DNA methylation
machinery. This lack of information may be due to difficulties
in identifying proteins that interact with Lsh. Indeed, based on
the observed molecular mass of the native LSH calculated
from biochemical fractionation experiments, we found that the
vast majority of the nuclear pool of LSH in human and mouse
cells appears to consist of free monomeric LSH. Therefore,
purification of a low-abundance LSH complex by traditional
chromatography methods would not have been feasible. Addi-
tionally, we observed that the full-length LSH had a strong
repressive effect when recruited to the promoters of reporter
genes in yeast, further complicating the use of yeast two-hybrid
screens for identification of LSH-interacting partners. Taking
advantage of our discovery that LSH behaved as a transcrip-
tional repressor in mammalian cells as well as in yeast, we used
luciferase reporter assays as a tool to determine which region
of LSH mediates transcriptional repression and to identify
proteins that interact with LSH in vivo. By recruiting truncated
LSH polypeptides to GAL binding sites upstream of the lucif-
erase reporter gene driven by the TK promoter, we found that
the N-terminal coiled-coil domain of LSH spanning amino
acids 1 to 226 was necessary and sufficient for transcriptional
silencing of the reporter. Therefore, it seemed plausible that
this region of LSH, which we designated the TRD, interacts
with corepressor proteins that modify chromatin into a tran-
scriptionally nonpermissive state.
As LSH-mediated silencing of the luciferase reporter was
sensitive to the deacetylase inhibitor TSA, we performed co-
immunoprecipitation assays and found that two HDACs,
HDAC1 and HDAC2, interact with LSH in vivo. Further, in
vitro experiments revealed that neither HDAC1 nor HDAC2
directly binds to LSH, suggesting that they are recruited to
LSH by other proteins. Given the previous reports that LSH
coimmunoprecipitates with de novo DNMTs from extracts of
mouse cells, we examined whether transcriptional silencing of
the luciferase reporter required the presence of DNMTs. In
human colorectal carcinoma HCT116 cells with targeted dis-
ruption of the DNMT3B gene (DNMT3B KO1) as well as cells
expressing low levels of N-terminally truncated DNMT1 pro-
tein (DNMT1 KO2), we observed a significant reduction of
LSH-mediated repression, indicating that these two DNMTs
could be involved in the recruitment of HDAC1 and HDAC2
to LSH. Our further experiments confirmed that LSH does not
coimmunoprecipitate with HDACs from extracts of DNMT3B
KO1 and DNMT1 KO2 cells. We also observed that the en-
dogenous LSH as well as GAL4BD-tagged LSH coimmuno-
precipitated with DNMT1 and DNMT3B from extracts of
HCT116 cells.
It has been previously reported that both DNMT1 and
DNMT3B interact with HDAC1 and HDAC2 in vitro and in
vivo (9, 10, 32). Therefore, it was possible that DNMT1 and
DNMT3B bind to LSH independently of each other and pro-
mote the recruitment of HDACs to LSH-targeted chromatin.
However, we found that although LSH coimmunoprecipitated
with DNMT3B from DNMT1 KO cells, it did not interact with
HDACs or the truncated DNMT1 in these cells and was un-
able to silence the luciferase reporter. Taken together, our
data suggest that DNMT1-bound HDAC1 and HDAC2 are
recruited to LSH indirectly via DNMT3B (Fig. 8). Our in vitro
pull-down experiments further support the in vivo reporter
assays and coimmunoprecipitation data. Interestingly, we ob-
served that when DNMT1 was overexpressed in DNMT3B KO
cells, it could, to some extent, rescue the transcriptional re-
pression of luciferase reporter mediated by GAL4BD-LSH. As
DNMT1 does not directly bind to LSH, it is possible that the
recruitment of DNMT1 to LSH may occur via DNMT3A or
some other protein. However, the first possibility seems un-
likely, since we did not detect DNMT3A protein in any of the
HCT116 wild-type or KO cell lines except DKO cells (not
shown). Given that overexpression of DNMT3B in DNMT1
KO cells transfected with GAL4DB-LSH also reduced the
expression of the luciferase reporter by about 30%, it is pos-
sible that DNMT3B can either function in transcriptional re-
pression independently of the truncated DNMT1 or, to some
extent but not very efficiently, interact with the C terminus of
DNMT1. The second interpretation seems plausible, since the
N-terminal portion of DNMT1(1–1125) did not fully rescue
LSH-mediated repression in DNMT1 KO cells compared to
the full-length DNMT1.
In summary, we have investigated whether and how LSH
interacts with the DNA methylation machinery in human cells
and found that the LSH-associated complex contains at least
four proteins: DNMT3B, DNMT1, HDAC1, and HDAC2. We
show that GAL4BD-mediated targeting of LSH to a TK pro-
moter driving the expression of a reporter gene results in
transcriptional silencing, which is dependent upon the recruit-
ment of HDACs via DNMT3B and DNMT1. However, tran-
scriptional repression and recruitment of DNMTs did not im-
mediately result in DNA methylation, as bisulfite sequencing
did not detect methylated CpGs at TK promoter sequences 4
days after GAL4BD-LSH and the reporter plasmid were co-
transfected into cells (see Fig. S3 in the supplemental mate-
rial). These observations are consistent with previous reports
that DNA methylation follows rather than precedes transcrip-
tional silencing established by negative transcriptional regula-
tors, including chromatin-related mechanisms (23, 40). Thus,
although LSH protein serves as a scaffold for assembly of the
DNMT/HDAC complex, the primary function of the LSH
complex may not be to methylate DNA but to establish
deacetylated inactive chromatin. Transcriptional repression
caused by deacetylation of histone tails by LSH-interacting
HDAC1/2 can be viewed as an initial and, perhaps, reversible
step in LSH-mediated heterochromatin formation. A longer-
term association of LSH with specific loci and a persistently
high local concentration of DNMT1 and DNMT3B may result
in methylation of CpGs at these loci. The kinetics of DNA
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methylation induced by the LSH-associated complex requires a
more detailed investigation. Nevertheless, experiments with
unmethylated episomal plasmids capable of replicating in
mammalian cells indicate that Lsh-facilitated DNA methyl-
ation was observed weeks after the plasmids were introduced
into these cells (45). Taken together, these data suggest that
LSH cooperates with DNMTs and HDAC1/2 to act as a gen-
eral transcriptional repressor in mammalian cells.
In mouse cells, Lsh as well as DNMT1 and DNMT3B are
required for DNA methylation of pericentromeric major sat-
ellite repeats. Yan et al. have reported that in Lsh-deficient
mouse embryonic fibroblasts, H3K4 dimethylation, a histone
modification associated with transcriptionally permissive chro-
matin, accumulates at normally heterochromatic, Lsh-bound
and H3K4-depleted pericentromeric sequences (43). Our ex-
periments provide a mechanistic explanation for the observed
increase of histone acetylation and other positive histone mod-
ifications at pericentric heterochromatin and other loci in
Lsh	/	 cells (41, 43).
It is still unclear whether and how LSH and/or the LSH-
associated DNMT complex is recruited to chromatin to estab-
lish transcriptionally silenced chromatin and DNA methylation
at specific loci. One could also envision that LSH continuously
scans chromatin for regions that challenge the processivity of
DNMT enzymes. How LSH recruitment is related to func-
tional states of chromatin and what makes certain loci pre-
ferred targets for LSH would be intriguing questions to answer.
Based on observations in plants that DNA methylation of
transposable elements and related tandem repeats is depen-
dent on small interfering RNA and DDM1, it has been sug-
gested that small interfering RNA may guide DDM1 to establish
heterochromatin at specific genomic locations (19). However, this
proposed model still awaits experimental proof in both plants and
in animal cells.
Thus far our preliminary experiments indicate that LSH
binds to DNA and to linker DNA regions of reconstituted
chromatin more efficiently than either DNMT3B or DNMT1
(data not shown) (27, 31). It is possible to envision that the
binding properties of the LSH complex as a whole are deter-
mined by the additive affinities of individual proteins, i.e., LSH,
DNMTs, and HDACs, for DNA and/or histones. In vitro re-
constitution of the LSH complex and further investigation of
how this complex interacts with nucleosomal DNA in vitro and
in vivo may provide interesting insights.
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